Keating Financial Advisory Services’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Keating Financial Advisory Services's HALO Position: Q2 2026 in Review
Keating Financial Advisory Services increased its Halozyme (HALO) stake by 47% in Q2 2026, buying an estimated $1.84K and bringing the position to 85 shares worth $6.65K. The position accounts for ﹤0.01% of the portfolio, ranked #1418.
Keating Financial Advisory Services first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Keating Financial Advisory Services held 85 shares of Halozyme worth $6.65K as of Q2 2026.
- Keating Financial Advisory Services bought 27 Halozyme shares in Q2 2026, an estimated $1.84K.
- Halozyme made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #1418 holding.
- Keating Financial Advisory Services first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.